Hostname: page-component-78c5997874-ndw9j Total loading time: 0 Render date: 2024-11-10T07:14:42.326Z Has data issue: false hasContentIssue false

[No Title]

Published online by Cambridge University Press:  03 January 2018

S. Swain
Affiliation:
Department of Neurochemistry, Institute of Human Behaviour & Allied Sciences (IHBAS), Shahdara, Delhi 110095, India
C. Pradhan
Affiliation:
Department of Psychiatry, Institute of Human Behaviour & Allied Sciences (IHBAS), Shahdara, Delhi 110095, India
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Copyright
Copyright © 1999 The Royal College of Psychiatrists 

References

Finkel, M. S., Thode, F. L., Pollock, B. J., et al (1996) Paroxetine: a novel nitric oxide synthetase inhibitor. Psychopharmacology Bulletin, 32, 653658.Google Scholar
Hamazaki, T., Sawazaki, S., Itomura, M., et al (1996) The effect of docosahexaenoic acid on aggression in young adults. Journal of Clinical Investigation, 97, 11291134.Google Scholar
Maes, M., Smith, R., Christophe, A., et al (1996) Fatty acid composition in major depression: Decreased ω3 fractions in cholesteryl esters and increased C 20: 4ω6/C20: 5ω3 ratio in cholesteryl esters and phospholipids. Journal of Affective Disorders, 38, 3546.Google Scholar
Peet, M., Hurphy, B., Shay, J., et al (1998) Depletion of omega–3 fatty acid levels in red blood cell membrane of depressive patients. Biological Psychiatry, 43, 315319.Google Scholar
Smith, R. S. (1991) The macrophage theory of depression. Medical Hypothesis, 35, 298306.Google Scholar
Walker, N. P., Fox, H. C. & Whalley, L. J. (1999) Lipids and schizophrenia. British Journal of Psychiatry, 174, 101104.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.